Celastrol directly targets LRP1 to inhibit fibroblast-macrophage crosstalk and ameliorates psoriasis progression
Top Cited Papers
Open Access
- 5 January 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (2) , 876-891
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responsesActa Pharmaceutica Sinica B, 2024
- Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activationDevelopmental Cell, 2021
- Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in miceActa Pharmaceutica Sinica B, 2021
- Excessive Polyamine Generation in Keratinocytes Promotes Self-RNA Sensing by Dendritic Cells in PsoriasisImmunity, 2020
- Interleukin-22 in human inflammatory diseases and viral infectionsAutoimmunity Reviews, 2017
- The good and the bad collagens of fibrosis – Their role in signaling and organ functionAdvanced Drug Delivery Reviews, 2017
- Prokineticin 2 Plays a Pivotal Role in PsoriasisEBioMedicine, 2016
- Mutations in LRPAP1 Are Associated with Severe Myopia in HumansThe American Journal of Human Genetics, 2013
- Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and AngiogenesisCell, 2012
- Surface location and high affinity for calcium of a 500‐kd liver membrane protein closely related to the LDL‐receptor suggest a physiological role as lipoprotein receptor.The EMBO Journal, 1988